Viewing Study NCT00743769


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-25 @ 8:26 PM
Study NCT ID: NCT00743769
Status: WITHDRAWN
Last Update Posted: 2017-04-17
First Post: 2008-08-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
Sponsor: RegeneRx Biopharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: RGN-MI-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators